Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses
Research and development costs	$ 4,788,807	$ 174,083
General and administrative expenses	20,499,052	5,322,362
Impairment of intangible assets and goodwill	38,678,918
Depreciation and amortization	656,643	120,872
Total operating expenses	64,623,420	5,617,317
Loss from operations	(64,623,420)	(5,617,317)
Other income (expense)
Interest expense	(10,316)	(445,250)
Change in fair value of warrant liabilities	9,327,326
Inducement expense	(1,125,291)	(802,109)
Total other income (expense)	8,191,719	(1,247,359)
Net loss before income taxes	(56,431,701)	(6,864,676)
Income tax benefit	7,454,805
Net loss after income tax benefit	(48,976,896)	(6,864,676)
Other comprehensive gain (loss)
Foreign currency translation gain (loss)	150,475	(169,655)
Comprehensive loss	$ (48,826,421)	$ (7,034,331)
Net loss per share – basic and diluted	$ (2.07)	$ (1.19)
Weighted average shares outstanding, basic and diluted	23,617,104	5,753,598